These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35688046)
1. Rejection sensitivity and mu opioid receptor dynamics associated with mood alterations in response to social feedback. Hill KR; Hsu DT; Taylor SF; Ogden RT; DeLorenzo C; Parsey RV Psychiatry Res Neuroimaging; 2022 Aug; 324():111505. PubMed ID: 35688046 [TBL] [Abstract][Full Text] [Related]
2. Response of the μ-opioid system to social rejection and acceptance. Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Wang H; Ni L; Walker SJ; Mickey BJ; Korycinski ST; Koeppe RA; Crocker JK; Langenecker SA; Zubieta JK Mol Psychiatry; 2013 Nov; 18(11):1211-7. PubMed ID: 23958960 [TBL] [Abstract][Full Text] [Related]
3. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder. Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108 [TBL] [Abstract][Full Text] [Related]
4. Interindividual variability and lateralization of μ-opioid receptors in the human brain. Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992 [TBL] [Abstract][Full Text] [Related]
5. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects. Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022 [TBL] [Abstract][Full Text] [Related]
6. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission. Prossin A; Koch A; Campbell P; Laumet G; Stohler CS; Dantzer R; Zubieta JK Mol Psychiatry; 2022 Feb; 27(2):831-839. PubMed ID: 34716408 [TBL] [Abstract][Full Text] [Related]
7. Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability. Karjalainen T; Tuominen L; Manninen S; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L Soc Cogn Affect Neurosci; 2016 Aug; 11(8):1310-6. PubMed ID: 27053768 [TBL] [Abstract][Full Text] [Related]
8. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms. Nuechterlein EB; Ni L; Domino EF; Zubieta JK Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017 [TBL] [Abstract][Full Text] [Related]
11. Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior. Simmons D; Self DW Neuropsychopharmacology; 2009 Jul; 34(8):1946-57. PubMed ID: 19279569 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118 [TBL] [Abstract][Full Text] [Related]
13. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression. Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634 [TBL] [Abstract][Full Text] [Related]
14. Aerobic Fitness Is Associated with Cerebral μ-Opioid Receptor Activation in Healthy Humans. Saanijoki T; Kantonen T; Pekkarinen L; Kalliokoski K; Hirvonen J; Malén T; Tuominen L; Tuulari JJ; Arponen E; Nuutila P; Nummenmaa L Med Sci Sports Exerc; 2022 Jul; 54(7):1076-1084. PubMed ID: 35195103 [TBL] [Abstract][Full Text] [Related]
15. Social Laughter Triggers Endogenous Opioid Release in Humans. Manninen S; Tuominen L; Dunbar RI; Karjalainen T; Hirvonen J; Arponen E; Hari R; Jääskeläinen IP; Sams M; Nummenmaa L J Neurosci; 2017 Jun; 37(25):6125-6131. PubMed ID: 28536272 [TBL] [Abstract][Full Text] [Related]
16. Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [ Shatalina E; Ashok AH; Wall MB; Nour MM; Myers J; Reis Marques T; Rabiner EA; Howes OD Neuroimage Clin; 2023; 39():103481. PubMed ID: 37517175 [TBL] [Abstract][Full Text] [Related]
17. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis. Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425 [TBL] [Abstract][Full Text] [Related]
18. Reduced mu opioid receptor availability in schizophrenia revealed with [ Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737 [TBL] [Abstract][Full Text] [Related]
19. μ-opioid receptor system mediates reward processing in humans. Nummenmaa L; Saanijoki T; Tuominen L; Hirvonen J; Tuulari JJ; Nuutila P; Kalliokoski K Nat Commun; 2018 Apr; 9(1):1500. PubMed ID: 29662095 [TBL] [Abstract][Full Text] [Related]
20. Adult attachment style is associated with cerebral μ-opioid receptor availability in humans. Nummenmaa L; Manninen S; Tuominen L; Hirvonen J; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Dunbar RI; Sams M Hum Brain Mapp; 2015 Sep; 36(9):3621-8. PubMed ID: 26046928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]